<DOC>
	<DOCNO>NCT02978534</DOCNO>
	<brief_summary>The widespread common use quetiapine childbearing pregnant woman demand data inform dose toxicity pregnancy . The new FDA Pregnancy Lactation Labeling Final Rule ( PLLR ) go effect June 30th , 2015 replace prior A , B , C , D , X category . Additionally , PLLR require information aid prescribing decision three category 1 ) Pregnancy ( include labor delivery ) , 2 ) Lactation , 3 ) Females Males Reproductive Potential . The pregnancy category include subsection describe pharmacokinetic pharmacodynamic characteristic medication pregnancy , fetal risk , data quality . The data collect study update FDA pregnancy pharmacokinetic section quetiapine inform physicians prescribe childbearing woman .</brief_summary>
	<brief_title>Pharmacokinetics Quetiapine Across Pregnancy Postpartum</brief_title>
	<detailed_description>Bipolar Disorder ( BD ) Schizophrenia ( SCHZ ) pregnancy associate pregnancy complication increase maternal mortality due physiological psychosocial change independent SGA use . Untreated BD SCHZ associate increase risk placental abnormality , antepartum hemorrhage , preterm birth , pre-eclampsia , low birth-weight , intrauterine growth retardation , small gestational age , fetal distress , neonatal hypoglycemia , stillbirth congenital defect , potential adverse neurodevelopmental outcome . Severe maternal stress pregnancy increase risk offspring mental disorder , eye , ear , respiratory , digestive , skin , musculoskeletal , genitourinary disease congenital malformation ( i.e. , cleft palate , cleave lip ) . Also , BD SCHZ illness symptom link psychosocial consequence result poor perinatal outcome include impulsivity lead reckless behavior increase indiscriminate sex exposure sexually transmitted infection , smoking , increase alcohol drug use , less prenatal care , poor nutrition . Furthermore , woman recurrence mental illness perinatal period increase risk suicide , lead cause maternal death . The published case quetiapine plasma concentration pregnant woman include cross-sectional level woman 300 mg quetiapine across pregnancy postpartum . Compared six month postpartum , area curve decrease 27 % , 42 % , 18 % first , second , third trimester , respectively . Given complexity metabolism quetiapine active metabolite , important understand alter metabolism quetiapine active metabolite pregnancy implication dose adjustment . This study investigate longitudinal pharmacokinetics quetiapine pregnancy , delivery , postpartum . The long-term goal line research establish psychotropic medication dose algorithm inform longitudinal pharmacokinetic data improve mental health pregnancy outcomes mother serious mental illness . The primary aim : 1 ) Determine elimination clearance quetiapine major active metabolite , 7-N-desalkyquetiapine , across pregnancy postpartum ; 2 ) Determine effect pharmacokinetic change symptoms toxicity pregnancy postpartum , ; 3 ) Examine maternal-to-cord plasma concentration ratios quetiapine major active metabolite , 7-N-desalkylquetiapine .</detailed_description>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>Age 1845 year Pregnant , second trimester Englishspeaking DSMV diagnosis Bipolar Disorder Schizophrenia , subtype Medically healthy Singleton gestation Chronic use drug medical disorder , except thyroid replacement stable hypothyroidism No psychiatrist obstetrician QIDSSR 16 positive answer 3 item 12 , `` I make specific plan suicide actually try take life '' within past week DSMV diagnosis substance abuse dependence last 6 month , exception cannabis ; positive urine drug screen</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>pregnant</keyword>
	<keyword>quetiapine</keyword>
	<keyword>bipolar</keyword>
	<keyword>woman</keyword>
	<keyword>female</keyword>
	<keyword>postpartum</keyword>
	<keyword>seroquel</keyword>
	<keyword>perinatal</keyword>
	<keyword>manic-depressive</keyword>
</DOC>